Labeling OTC Human Drug Products Using a Column Format
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 19, 2000
May 14, 2020
538c56e4-5604-47c8-9451-300e5f66cf8f
Related Documents
Street Drug Alternatives
Guidance DocumentApril 3, 2000Center for Drug Evaluation and Research
Labeling OTC Human Drug Products Updating Labeling in RLDs and ANDAs
Guidance DocumentOctober 18, 2002Center for Drug Evaluation and Research
Alternate Source of the Active Pharmaceutical Ingredient in Pending ANDAs: Guidance for Industry
Guidance DocumentDecember 1, 2000Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.